177 related articles for article (PubMed ID: 2992637)
1. Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population.
Foa R; Giovarelli M; Jemma C; Fierro MT; Lusso P; Ferrando ML; Lauria F; Forni G
Blood; 1985 Sep; 66(3):614-9. PubMed ID: 2992637
[TBL] [Abstract][Full Text] [Related]
2. Release of interleukin-2-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization?
Giovarelli M; Foa R; Benetton G; Lusso P; Fierro MT; Forni G
Leuk Res; 1988; 12(3):201-9. PubMed ID: 3259277
[TBL] [Abstract][Full Text] [Related]
3. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
4. Tac-positive, HTLV-negative, T helper phenotype chronic lymphocytic leukemia cells.
Pandolfi F; De Rossi G; Ranucci A; Bonomo G; Pasqualetti D; Napolitano M; Manzari V
Blood; 1985 Jun; 65(6):1531-7. PubMed ID: 2986747
[TBL] [Abstract][Full Text] [Related]
5. Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type.
Rossi JF; Commes T; Grenier J; Jourdan M; Chichehian B; Klein B
Am J Hematol; 1988 Dec; 29(4):183-8. PubMed ID: 3142255
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
[TBL] [Abstract][Full Text] [Related]
7. Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B cell variety.
Ayanlar-Batuman O; Ebert E; Hauptman SP
Blood; 1986 Feb; 67(2):279-84. PubMed ID: 2935203
[TBL] [Abstract][Full Text] [Related]
8. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
9. Effect of a thymic factor on T lymphocytes in B cell chronic lymphocytic leukemia: in vitro and in vivo studies.
Lauria F; Raspadori D; Tura S
Blood; 1984 Sep; 64(3):667-71. PubMed ID: 6235869
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture.
Vyth-Dreese FA; de Vries JE
Leuk Res; 1984; 8(1):1-14. PubMed ID: 6321859
[TBL] [Abstract][Full Text] [Related]
11. T cell growth-promoting activity of interferon-gamma. Mitogenic effect of the recombinant cytokine on cells from a human T-chronic lymphocytic leukemia.
Alfinito F; Lamberti A; Capobianchi MR; Nigro M; De Rosa G; Tassone P; Turco MC; Dianzani F; Venuta S
Leukemia; 1994 Aug; 8(8):1294-300. PubMed ID: 8057665
[TBL] [Abstract][Full Text] [Related]
12. Immunoregulation of B lymphocyte colony formation by T cell subsets in patients with chronic lymphocytic leukemia.
Fernandez LA; MacSween JM; Langley GR
Blood; 1986 Feb; 67(2):294-8. PubMed ID: 2935205
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 production in B cell chronic lymphocytic leukemia.
Rossi JF; Klein B; Commes T; Jourdan M
Blood; 1985 Oct; 66(4):840-7. PubMed ID: 3876123
[TBL] [Abstract][Full Text] [Related]
14. Production of lymphokines by circulating human T lymphocytes that express or lack receptors for interleukin 2.
Palacios R
J Immunol; 1984 Apr; 132(4):1833-6. PubMed ID: 6321592
[TBL] [Abstract][Full Text] [Related]
15. In vitro function of a T-cell chronic lymphocytic leukemia with suppressor cell phenotype.
Crosier PS
Aust N Z J Med; 1986 Jun; 16(3):389-92. PubMed ID: 2946284
[TBL] [Abstract][Full Text] [Related]
16. OT-CLL: a human T cell chronic lymphocytic leukemia that produces IL 2 in high titer.
Friedman SM; Thompson G; Halper JP; Knowles DM
J Immunol; 1982 Feb; 128(2):935-40. PubMed ID: 6976389
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies.
Davis S
Blood; 1981 Nov; 58(5):1053-5. PubMed ID: 6975137
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
Benjamin D; Bazar LS; Wallace B; Jacobson RJ
Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
[TBL] [Abstract][Full Text] [Related]
19. Defective interferon-gamma production in ataxia-telangiectasia.
Paganelli R; Capobianchi MR; Matricardi PM; Cioè L; Seminara R; Dianzani F; Aiuti F
Clin Immunol Immunopathol; 1984 Sep; 32(3):387-91. PubMed ID: 6432389
[TBL] [Abstract][Full Text] [Related]
20. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
